NCT00003463View on ClinicalTrials.gov

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1998

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

carmustine

DRUG

irinotecan hydrochloride

DRUG

polifeprosan 20 with carmustine implant

PROCEDURE

surgical procedure

Trial Locations (2)

27710

Duke Comprehensive Cancer Center, Durham

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER